PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth of 100.00% while ECL.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
10.33%
Gross profit growth of 10.33% while ECL.AX is zero. Bruce Berkowitz would see if minimal improvements could expand further.
78.01%
EBIT growth of 78.01% while ECL.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
78.01%
Operating income growth of 78.01% while ECL.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
100.00%
Net income growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
100.00%
Positive EPS growth while ECL.AX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
90.00%
Positive diluted EPS growth while ECL.AX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.88%
Share change of 0.88% while ECL.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.61%
Diluted share change of 1.61% while ECL.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while ECL.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-100.08%
Negative FCF growth while ECL.AX is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
26555.94%
10Y revenue/share CAGR above 1.5x ECL.AX's 247.41%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1181.48%
5Y revenue/share CAGR above 1.5x ECL.AX's 65.98%. David Dodd would look for consistent product or market expansions fueling outperformance.
273.22%
3Y revenue/share CAGR above 1.5x ECL.AX's 19.44%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-4108.13%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-13639.91%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-243.07%
Negative 3Y OCF/share CAGR while ECL.AX stands at 20088.62%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
1403.26%
Net income/share CAGR above 1.5x ECL.AX's 703.70% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
3061.96%
5Y net income/share CAGR 1.25-1.5x ECL.AX's 2138.76%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
440.05%
Below 50% of ECL.AX's 1363.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
60878.89%
10Y equity/share CAGR above 1.5x ECL.AX's 143.66%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
235.90%
5Y equity/share CAGR above 1.5x ECL.AX's 141.16%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
64.91%
3Y equity/share CAGR at 50-75% of ECL.AX's 116.14%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.21%
AR growth of 32.21% while ECL.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
3.65%
Asset growth of 3.65% while ECL.AX is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
-0.87%
We have a declining book value while ECL.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
3.31%
Debt growth of 3.31% while ECL.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-4.59%
We cut SG&A while ECL.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.